QIT - Quantum Informatics
From 01-01-2003 to 31-12-2006
Description
This project concerns the study of quantum entanglement with a major focus an entanglement distillation protocols. We see three main reasons for studying entanglement distillation protocols. The first and most obvious reason is that entanglement distillation protocols are a means of obtaining states that are closer to maximally entangled pure states, as needed in typical applications like teleportation, from mixed states that can be reached by sending one qubit of an entangled pair through a realistic channel. A second reason to study distillation protocols is that asymptotic protocols yield a lower bound for "entanglement of distillation", an important measure of entanglement, that is in itself a lower bound for any sensible measure of entanglement. A third reason is that multi-copy entanglement protocols can be considered as applications of entanglement, where more can be done in the presence of entangled pairs than without. We hope that studying these mechanisms will reveal some information on the important problem of how exactly the presence of entanglement enables one to do things that are impossible without.Team
- Jeroen Dehaene, Coordinator
- Bart De Moor, Promoter
- Maarten Van den Nest, Team member (External)
- Erik Hostens, Team member
Financing
Funding: FWO - Research Foundation - Flanders
Program/Grant Type: FWO Research Grant - FWO Research Grant
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.